These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26585744)

  • 41. [Statin therapy--for whom?].
    Kahri J; Syvänne M
    Duodecim; 2012; 128(8):811-8. PubMed ID: 22616372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
    Chen YH; Feng B; Chen ZW
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What do the statins tell us?
    LaRosa JC
    Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis.
    Gutierrez J; Ramirez G; Rundek T; Sacco RL
    Arch Intern Med; 2012 Jun; 172(12):909-19. PubMed ID: 22732744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuation of statin therapy and primary prevention of nonfatal cardiovascular events.
    Shalev V; Goldshtein I; Porath A; Weitzman D; Shemer J; Chodick G
    Am J Cardiol; 2012 Dec; 110(12):1779-86. PubMed ID: 23021514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
    Moyad MA; Merrick GS
    Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Statins under fire: justified or not?].
    Declerck E; De Loof H; De Meyer GR
    J Pharm Belg; 2009 Dec; (4):119-30. PubMed ID: 20183988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis.
    Yourman LC; Cenzer IS; Boscardin WJ; Nguyen BT; Smith AK; Schonberg MA; Schoenborn NL; Widera EW; Orkaby A; Rodriguez A; Lee SJ
    JAMA Intern Med; 2021 Feb; 181(2):179-185. PubMed ID: 33196766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initiating statins in the elderly: the evolving challenge.
    Walker DB; Jacobson TA
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):182-7. PubMed ID: 18316955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins in primary prevention: impact on mortality. A meta-analysis study.
    Nunes JP
    Minerva Cardioangiol; 2017 Oct; 65(5):531-538. PubMed ID: 28249380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up.
    Lv HL; Jin DM; Liu M; Liu YM; Wang JF; Geng DF
    Pharmacol Res; 2014 Mar; 81():64-73. PubMed ID: 24602799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statins and Elderly: From Clinical Trials to Daily Practice.
    Verdoia M; Galasso G; Filardi PP; De Luca G
    Curr Vasc Pharmacol; 2019; 17(3):233-238. PubMed ID: 29956633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary prevention of cardiovascular diseases with statins in women].
    Alici G; Karpuz V; Karpuz H
    Turk Kardiyol Dern Ars; 2009 Jun; 37(4):273-80. PubMed ID: 19717964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between Statins Prescribed for Primary and Secondary Prevention and Major Adverse Cardiac Events among Older Adults with Frailty: A Systematic Review.
    Hale M; Zaman H; Mehdizadeh D; Todd O; Callaghan H; Gale CP; Clegg A
    Drugs Aging; 2020 Nov; 37(11):787-799. PubMed ID: 32929609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of statin monotherapy in older adults: a meta-analysis.
    Roberts CG; Guallar E; Rodriguez A
    J Gerontol A Biol Sci Med Sci; 2007 Aug; 62(8):879-87. PubMed ID: 17702880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality.
    Lavie G; Hoshen M; Leibowitz M; Benis A; Akriv A; Balicer R; Reges O
    Am J Med; 2021 May; 134(5):643-652. PubMed ID: 33217370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholesterol lowering with statins: how WOSCOPS confounded the skeptics.
    Shepherd J
    Atheroscler Suppl; 2007 Aug; 8(2):9-12. PubMed ID: 17586101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.